At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18,113 enrolled
Drug / intervention
Candesartan Cilexetildrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Blopress Tablets Special Drug Use Surveillance 「Challenge - Quality Control」
In Brief
An observational study evaluating Candesartan Cilexetil for Hypertension. Completed, enrolled 18,113 participants across 1 site.
Detailed Summary
The purpose of this study is to gain an understanding of the actual use of candesartan cilexetil (Blopress) in patients with hypertension, and to examine the changes in parameters such as blood pressure.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2011
Primary CompletionApr 2013
First PostedAug 2014
TodayJul 2026
First PostedAug 7, 2014
Enrollment StartJun 13, 2011
Primary CompletionApr 25, 2013
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 11.9 years ago
Interventions
Candesartan Cilexetildrug
Candesartan Cilexetil tablet